54(top 2%)
papers
939(top 2%)
citations
17(top 2%)
h-index
31(top 2%)
g-index
55
all documents
1.0K
doc citations
478
citing journals

Top Articles

#TitleJournalYearCitations
1Effect and Treatment of Chronic Pain in Inflammatory ArthritisCurrent Rheumatology Reports2013113
2Uric acid lowering therapy: prescribing patterns in a large cohort of older adultsAnnals of the Rheumatic Diseases2007100
3Improving Care of Patients At-Risk for Osteoporosis: A Randomized Controlled TrialJournal of General Internal Medicine200773
4Surrogate-assisted feature extraction for high-throughput phenotypingJournal of the American Medical Informatics Association: JAMIA201768
5Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challengesOsteoporosis International201356
6Enhancing function in older adults with chronic low back pain: a pilot study of endurance training11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.Archives of Physical Medicine and Rehabilitation200354
7Specific systemic lupus erythematosus disease manifestations in the six months prior to conception are associated with similar disease manifestations during pregnancyLupus201537
8Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitisRheumatology201937
9Macrophages regulate lung ILC2 activation via Pla2g5-dependent mechanismsMucosal Immunology201836
10Patient adherence with a smartphone app for patient-reported outcomes in rheumatoid arthritisRheumatology202134
11Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate UseJournal of Clinical Endocrinology and Metabolism201928
12A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trialOsteoporosis International201027
13Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trialRheumatology201826
14Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction ruleOsteoporosis International201124
15Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort studyOsteoporosis International201624
16Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple SclerosisJAMA Network Open202123
17Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort studyRheumatology201122
18Circulating plasma metabolites and risk of rheumatoid arthritis in the Nurses’ Health StudyRheumatology202021
19Leveraging electronic health records data to predict multiple sclerosis disease activityAnnals of Clinical and Translational Neurology202119
20Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction TrialACR Open Rheumatology202018
21Coronary microvascular dysfunction in patients with psoriasisJournal of Nuclear Cardiology202218
22Ninety-One Osteoporosis Patients Affected with Bisphosphonate-Related Osteonecrosis of the Jaw: A Case SeriesCalcified Tissue International201317
23Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in RemissionJAMA - Journal of the American Medical Association202117
24Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trialsRheumatology202016
25Skin Involvement in Psoriatic Arthritis Worsens Overall Disease Activity, Patient-Reported Outcomes, and Increases Healthcare Resource Utilization: An Observational, Cross-Sectional StudyRheumatology and Therapy201815
26Efficacy of leflunomide in the treatment of vasculitisClinical and Experimental Rheumatology202114
27Prevalence and predictors for sustained remission in rheumatoid arthritisPLoS ONE201912
28Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitisArthritis Research and Therapy202212
29Case 3-2003New England Journal of Medicine200311
30Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiativeArchives of Dermatological Research201810
31Medical Records-Based Genetic Studies of the Complement SystemJournal of the American Society of Nephrology: JASN202110
32Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registriesBMC Medical Research Methodology20177
33The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapyArthritis Research and Therapy20217
34Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) InitiativeAmerican Journal of Clinical Dermatology20206
35To What Extent Can Preventive Treatments Prevent Damage From Systemic Lupus Erythematosus?Current Rheumatology Reports20113
36AB0554 SLEEP QUALITY IN PATIENTS WITH PSORIATIC ARTHRITISAnnals of the Rheumatic Diseases20213
37OP0115 EFFECT OF NINTEDANIB ON PROGRESSION OF INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED ILDS: FURTHER DATA FROM THE INBUILD TRIALAnnals of the Rheumatic Diseases20203
38Postfracture interventions disseminated through health care and drug insurers: attempting to integrate fragmented health care deliveryOsteoporosis International20112
39Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurementArthritis Research and Therapy20172
40Blood pressure lowering medication initiation and fracture risk: a SWAN pharmacoepidemiology studyArchives of Osteoporosis20192
41Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease ControlJAMA - Journal of the American Medical Association20232
42FAST4WARD: implications for the clinicianInternational Journal of Clinical Practice20091
43A7.16 Lack of Replication ofPTPRC Geneas a Predictor of Response to Anti-Tumour Necrosis Factor Therapy in Patients with Rheumatoid ArthritisAnnals of the Rheumatic Diseases20131
44AB0103 On-demand drug delivery from self-assembled hydrogels: a new approach for treatment of inflammatory arthritisAnnals of the Rheumatic Diseases20131
45Patterns of treatment among a cohort of older low-income adults starting new medications for osteoporosisOsteoporosis International20141
46From Paris to Vienna—The Varied Names and Descriptions of Cutaneous Lupus Erythematosus in the 19th CenturyJAMA Dermatology20171
47Neuropsychiatric Manifestations of Systemic Lupus Erythematosus20191
48Acknowledgments for “Best Practices in Systems-Based Interventions to Reduce the Burden of Fractures” (Osteoporosis International Volume 22, Supplement 3, August 2011)Osteoporosis International20120
49SAT0040 Prevalence and Predictors for Sustained Remission in Rheumatoid ArthritisAnnals of the Rheumatic Diseases20130
50Successful desensitization in a patient with Von Willebrand´s disease and anaphylaxis to factor VIII/VWClinical and Translational Allergy20140